Scott Heyward's Biography

Scott Heyward, Director, Research and Development & Scientific Affairs, BioIVT

Scott Heyward is currently the Director of Research and Development at BioIVT for hepatic products in our ADME-Tox division. He works on both new product development as well as support of application development for liver models for both drug development and hepatic biology. Prior to joining BioIVT he worked in a diverse set of biological areas spanning developmental biology, gene therapy, and virology, with a focus on hepatotropic viruses. His research interest focus on incorporating pharmacogenomics, liver non-parenchymal biology and long-term hepatocyte culture systems into predictive ADME-Tox models.